Evidence map›Paper›PMID 24055403›Full record

ArticleNeuroscience2013

The role of androgen receptor in transcriptional modulation of cannabinoid receptor type 1 gene in rat trigeminal ganglia.

K S Lee, J Asgar, Y Zhang, M-K Chung, J Y Ro

Open access · greenAbstract read
In one paragraph

Article in Neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Review
  17. Article
  18. Article
  19. Article
  20. Epigenetic Effects of Cannabis Exposure.Biological psychiatry · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

K S LeeUniversity of Maryland Dental School, Department of Neural and Pain Sciences, Program in Neuroscience, Baltimore, MD 21201, USA.
J Asgar
Y Zhang
M-K Chung
J Y Ro
University of Maryland, Baltimore · US

Funding

Sex-Differences in Peripheral Opioid Receptor MechanismsR01DE019448 · NIDCR · UNIVERSITY OF MARYLAND BALTIMORE · PI RO, JIN Y · 2008 to 2012
$1.8M
NIDCR NIH HHS R01 DE019448NIDCR NIH HHS R01DE19448
6 · The paper itself

Abstract

We have previously shown that anti-hyperalgesic effects of cannabinoid agonists under inflammatory condition are much greater in male than female, and that inflammatory cytokines upregulate cannabinoid receptor type 1 (CB1) expression in male, but not female, trigeminal ganglia (TG) in a testosterone-dependent manner. In this study, we investigated the mechanisms underlying the testosterone-mediated regulation of peripheral CB1 expression. We hypothesized that testosterone upregulates CB1 through transcriptional modulation by androgen receptor (AR). Interleukin-1 beta (IL-1β), a pro-inflammatory cytokine, upregulated CB1 mRNA expression in TG of male rats. The cytokine-induced upregulation was prevented by the pretreatment with flutamide, a specific antagonist for AR, but not by ICI 182,780, a specific antagonist for estrogen receptor, suggesting that the effects of testosterone are not mediated by estradiol, a testosterone metabolite. The expression levels of AR and IL-1β receptors were comparable between male and female TG, suggesting that the male specific IL-1β effects on CB1 upregulation occurs downstream to these receptors. The chromatin immunoprecipitation assay showed AR binding to the CB1 promoter in the rat TG. Furthermore, luciferase reporter assay revealed that AR activated the CB1 gene in response to testosterone or dihydrotestosterone treatment. These experiments provided compelling evidence that testosterone regulates CB1 gene transcription in TG through AR following cytokine stimulation. These results should provide mechanistic bases for understanding cytokine-hormone-neuron interactions in peripheral cannabinoid systems, and have important clinical implications for pain patients in whom testosterone level is naturally low, gradually declining or pharmacologically compromised.

Indexed as

AnimalsBase SequenceCell Line, TumorCells, CulturedFemaleHumansMaleMolecular Sequence DataProtein BindingRatsReceptor, Cannabinoid, CB1Receptors, AndrogenTranscription, GeneticTrigeminal GanglionReceptor, Cannabinoid, CB1Receptors, Androgenanalysis of varianceandrogen receptorANOVAARcannabinoid receptor 1cannabinoid receptor type 1CB1ChIPchromatin immunoprecipitationCnr1cytokinesEDTAERestrogen receptorethylenediaminetetraacetic acidIL-1RIL-1βinflammationinterleukin-1 betainterleukin-1 beta receptorPBSphosphate-buffered salineradio-immunoprecipitation assayratreverse transcription polymerase chain reactionRIPART-PCRsensory neuronstestosteroneTGtrigeminal ganglia

Identifiers

PMID24055403
PMCPMC3870904
OpenAlexW1993388011

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.